MedPath
FDA Approval

Levalbuterol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Bryant Ranch Prepack
DUNS: 171714327
Effective Date
September 14, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levosalbutamol(1.25 mg in 3 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Bryant Ranch Prepack

171714327

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bryant Ranch Prepack

Bryant Ranch Prepack

Bryant Ranch Prepack

171714327

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levalbuterol

Product Details

NDC Product Code
72162-2083
Application Number
ANDA203653
Marketing Category
ANDA (C73584)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
September 14, 2023
Code: WDQ1526QJMClass: ACTIMQuantity: 1.25 mg in 3 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Levalbuterol HCl 1.25 mg Solution #25

Label


© Copyright 2025. All Rights Reserved by MedPath